Oric Pharmaceuticals, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ORIC Company Description
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
ORIC Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ORIC Smart Score
Score Breakdown
ORIC Company Description
Show More
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ORIC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ORIC's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of ORIC in WallStreetBets Daily Discussion
ORIC News
Recent insights relating to ORIC
CNBC Recommendations
Recent picks made for ORIC stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ORIC
Corporate Flights
Flights by private jets registered to ORIC
Our Analysis